For additional information regarding investigative sites for this trial, call (858) 794-8889 8 AM to 5 PM Mon-Fri Pacific Standard Time

Atlanta, Georgia 30318

0 studies enrolling now · 1 studies all time

What they study most

Type 1 Diabetes Mellitus

Studies at this site

• CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Participants With Type 1 Diabetes Mellitus (T1DM) — Completed